This can lead to the hypothesis that myelofibrosis‐derived fibroblasts, acting as cancer‐associated fibroblasts, are highly dependent on TGFBR1, with a possible compensatory down‐regulation of TGFBR2 (Figure 3A). The gene discussed is TGFBR2; the disease is myelofibrosis.